Endpoint | Characteristic | HR | 95.0% CI | P | |
---|---|---|---|---|---|
RFS | Treatment method | 0.667 | 0.467 | 0.953 | 0.026 |
DMFS | |||||
Treatment method | 0.694 | 0.561 | 0.859 | 0.001 | |
N stage | 2.560 | 1.304 | 5.029 | 0.006 | |
T stage | 1.772 | 1.246 | 2.522 | 0.001 | |
PFS | |||||
Treatment method | 0.674 | 0.556 | 0.818 | <0.001 | |
T stage | 1.645 | 1.190 | 2.275 | 0.003 | |
N stage | 2.004 | 1.039 | 3.867 | 0.038 | |
OS | Treatment method | 0.621 | 0.497 | 0.775 | <0.001 |
N stage | 2.782 | 1.372 | 5.642 | 0.005 | |
T stage | 1.902 | 1.321 | 2.740 | 0.001 |